TC-2216

TargetMol
Product Code: TAR-T68154
Supplier: TargetMol
CodeSizePrice
TAR-T68154-1mg1mg£140.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68154-5mg5mg£231.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68154-10mg10mg£311.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68154-25mg25mg£541.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68154-50mg50mg£713.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68154-100mg100mg£946.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68154-500mg500mg£1,862.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C

Images

1 / 1

Further Information

Bioactivity:
TC-2216 is a partial agonist at the neural nicotinic acetylcholine receptor and is used to treat anxiety and depression.
CAS:
646055-67-6
Molecular Weight:
203.28
Pathway:
Neuroscience
Purity:
0.98
SMILES:
N=1C=CC=C(C1)N2CCC3(NCCC3)C2
Target:
AChR

References

Lippiello PM, et al. TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity. CNS Neurosci Ther. 2008;14(4):266-277. Lee R F, et al. Citrus blight: attempts to get remission of symptoms by chemotherapy. Proceedings of the Florida State Horticultural Society. 1981; 94: 21-24. Strachan JP, et al. Diazaspirocyclic compounds as selective ligands for the ?4?2 nicotinic acetylcholine receptor. Bioorg Med Chem Lett. 2012;22(15):5089-5092. Sippy KB, et al. Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors. Bioorg Med Chem Lett. 2009;19(6):1682-168 Capelli AM, et al. Stable expression and functional characterization of a human nicotinic acetylcholine receptor with ?6?2 properties: discovery of selective antagonists. Br J Pharmacol. 2011;163(2):313-329.